PO.PR01.01 · 预防研究

非裔美国女性三阴性乳腺癌中的应激反应性免疫微环境

Stress-responsive immune microenvironment in triple-negative breast cancer among African American women

海报缩略图:非裔美国女性三阴性乳腺癌中的应激反应性免疫微环境
编号 2375 展板 11 时间 4/20 09:00–12:00 区域 Section 37 主讲 Aminah Lawal, No Degree
分会场 Cancer Disparities
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Aminah M. Lawal1, Fulya Koksalar Alkan1, Hilmi Kaan Alkan1, Ahmet Burak Caglayan2, Neva Celiker1, Brianna Temby1, MAX WICHA2, Morhaf Al Achkar1, Kristen Purrington1, Hasan Korkaya1

1Wayne State University, Detroit, MI,2University of Michigan, Ann Arbor, MI

摘要 Abstract

中文摘要
非裔美国(AA)女性三阴性乳腺癌(TNBC)的发病率和死亡率高于白人女性,尤其是在较年轻年龄段。虽然社会经济决定因素造成了这一差异,但新兴证据表明,慢性社会应激会在生物学上被固化,重塑全身炎症和肿瘤免疫微环境(TIME)。我们假设,应激反应性炎症信号驱动免疫抑制性髓系细胞群的积累,从机制上促成AA TNBC中增强的癌症干性和侵袭性肿瘤行为。使用对入组Karmanos癌症研究所生物样本库的(n=4)AA和(n=4)白人患者TNBC肿瘤进行的空间转录组学,我们识别出AA肿瘤中富集的独特免疫和应激反应程序。AA样本显示免疫抑制性髓系群体显著增加,包括TAM样和MDSC样簇,同时伴随IL1B、TNFA相关细胞因子模块、S100A8/S100A9及其他固有炎症细胞因子的表达升高。这些炎症程序与应激反应通路的激活相关,最显著的是HSP70——细胞应激、危险信号传导和抗原呈递的核心调节因子。从机制上看,这些通路与癌症干性特征的转录激活紧密相连,包括NQO2、IRF3相关应激模块及其他干性相关基因,与AA TNBC肿瘤中更具可塑性、耐药的表型相一致。既往研究表明,感知到的歧视、支持不足和邻里劣势等慢性社会应激源与全身炎症和免疫反应改变相关。我们的肿瘤层面分析提示,这种应激激活的信号可能汇聚于TIME内的固有免疫通路,放大髓系抑制、细胞因子激活和应激诱导的干性,共同恶化结局。假设AA患者比白人患者经历更高的社会应激,这些结果支持一种机制模型,即社会心理应激使固有免疫微环境趋向免疫功能障碍和髓系主导,促进AA TNBC的肿瘤可塑性和转移潜能。了解应激反应性免疫程序如何塑造肿瘤演化,可能揭示可作为靶点的干预点,以减轻生物学介导的癌症差异,并指导整合免疫学、社会决定因素和精准肿瘤学的干预措施。
查看英文原文 English abstract
African American (AA) women experience higher incidence and mortality from triple-negative breast cancer (TNBC) compared to White women, particularly at younger ages. While socioeconomic determinants contribute to this disparity, emerging evidence indicates that chronic social stress becomes biologically embedded, reshaping systemic inflammation and the tumor immune microenvironment (TIME). We hypothesize that stress-responsive inflammatory signaling drives the accumulation of immune suppressive myeloid cell populations contributing mechanistically to enhanced cancer stemness and aggressive tumor behavior in AA TNBC.Using spatial transcriptomics on TNBC tumors from (n=4) AA and (n=4) White patients enrolled in the Karmanos Cancer Institute Biobank, we identified distinct immune and stress-response programs enriched in AA tumors. AA samples displayed a marked increase in immunosuppressive myeloid populations, including TAM-like and MDSC-like clusters, accompanied by heightened expression of IL1B, TNFA-associated cytokine modules, S100A8/S100A9, and other innate inflammatory cytokines. These inflammatory programs correlated with activation of stress-response pathways, most notably HSP70, a central regulator of cellular stress, danger signaling, and antigen presentation. Mechanistically, these pathways were tightly linked to a transcriptional activation of cancer stemness signatures, including NQO2, IRF3-associated stress modules, and other stem-associated genes, consistent with a more plastic, therapy-resistant phenotype in AA TNBC tumors.Previous studies have shown that chronic social stressors such as perceived discrimination, inadequate support, and neighborhood disadvantage have been associated with systemic inflammation and altered immune response. Our tumor-level analyses suggest that this stress activated signaling may converge on innate immune pathways within the TIME, amplifying myeloid suppression, cytokine activation, and stress-induced stemness that collectively worsened outcomes.Hypothesizing that AA patients experience higher social stress than White patients, these results support a mechanistic model in which psychosocial stress primes the innate immune microenvironment toward immune dysfunction and myeloid dominance, promoting tumor plasticity and metastatic potential in AA TNBC. Understanding how stress-responsive immunologic programs shape tumor evolution may reveal actionable targets to mitigate biologically mediated cancer disparities and guide interventions integrating immunology, social determinants, and precision oncology.
利益披露 Disclosure
A. M. Lawal, None.. F. Koksalar Alkan, None.. H. Alkan, None.. A. Caglayan, None.. N. Celiker, None.. B. Temby, None.. M. Wicha, None.. M. Al Achkar, None.. K. Purrington, None.. H. Korkaya, None.

← 返回 AACR 2026 检索